Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing

A report from the prospective COST trial

Kellie L. Mathis, Erin M. Green, Daniel J. Sargent, Conor Delaney, Clifford L. Simmang, Heidi Nelson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVE: We tested the hypothesis that the 12 lymph node (LN) count and other surgical variables would not predict survival in a setting where surgical techniques were standardized and surgeons were credentialed and audited. BACKGROUND: The National Quality Forum has adopted the 12-node minimum as a surgical quality metric due to the strong association between node count and survival. METHODS: We performed a secondary analysis of data from the Clinical Outcomes of Surgical Therapy (COST) multicenter randomized trial testing laparoscopic versus open colectomy. Surgeons were credentialed and video-audited for adherence to technical standards. Patients with noninvasive and stage IV disease were excluded, leaving 787 subjects (267 stage I, 284 stage II, and 236 stage III). Median age was 70 years and 50% were male. The overall 5-year survival was 77.2%. RESULTS: Five-year overall and disease-free survival was not influenced by LN count (< 12 vs 12), sex, tumor location (right vs left vs sigmoid), surgical technique (laparoscopic vs open), total bowel length, proximal margin, distal margin, radial margin, or mesenteric length (P > 0.05 for all). Univariate predictors of survival included age and cancer stage, and these remained significant in the multivariate model. Across all stages of disease, after adjusting for age and stage, LN count did not predict overall or disease-free survival (P = 0.60). CONCLUSIONS: Despite the known association between LN count and survival, we could not confirm an association between surgical surrogates and cancer outcomes. We postulate that standardization, credentialing, and monitoring may be more important than traditional surgical quality surrogates.

Original languageEnglish (US)
Pages (from-to)102-107
Number of pages6
JournalAnnals of Surgery
Volume257
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Credentialing
Colonic Neoplasms
Lymph Nodes
Survival
Disease-Free Survival
Therapeutics
Colectomy
Multicenter Studies
Neoplasms

Keywords

  • Colon cancer
  • laparoscopy
  • lymph node count
  • quality
  • survival

ASJC Scopus subject areas

  • Surgery

Cite this

Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing : A report from the prospective COST trial. / Mathis, Kellie L.; Green, Erin M.; Sargent, Daniel J.; Delaney, Conor; Simmang, Clifford L.; Nelson, Heidi.

In: Annals of Surgery, Vol. 257, No. 1, 01.2013, p. 102-107.

Research output: Contribution to journalArticle

Mathis, Kellie L. ; Green, Erin M. ; Sargent, Daniel J. ; Delaney, Conor ; Simmang, Clifford L. ; Nelson, Heidi. / Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing : A report from the prospective COST trial. In: Annals of Surgery. 2013 ; Vol. 257, No. 1. pp. 102-107.
@article{d7f5573517f04b0dbd14f9645b058a70,
title = "Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: A report from the prospective COST trial",
abstract = "OBJECTIVE: We tested the hypothesis that the 12 lymph node (LN) count and other surgical variables would not predict survival in a setting where surgical techniques were standardized and surgeons were credentialed and audited. BACKGROUND: The National Quality Forum has adopted the 12-node minimum as a surgical quality metric due to the strong association between node count and survival. METHODS: We performed a secondary analysis of data from the Clinical Outcomes of Surgical Therapy (COST) multicenter randomized trial testing laparoscopic versus open colectomy. Surgeons were credentialed and video-audited for adherence to technical standards. Patients with noninvasive and stage IV disease were excluded, leaving 787 subjects (267 stage I, 284 stage II, and 236 stage III). Median age was 70 years and 50{\%} were male. The overall 5-year survival was 77.2{\%}. RESULTS: Five-year overall and disease-free survival was not influenced by LN count (< 12 vs 12), sex, tumor location (right vs left vs sigmoid), surgical technique (laparoscopic vs open), total bowel length, proximal margin, distal margin, radial margin, or mesenteric length (P > 0.05 for all). Univariate predictors of survival included age and cancer stage, and these remained significant in the multivariate model. Across all stages of disease, after adjusting for age and stage, LN count did not predict overall or disease-free survival (P = 0.60). CONCLUSIONS: Despite the known association between LN count and survival, we could not confirm an association between surgical surrogates and cancer outcomes. We postulate that standardization, credentialing, and monitoring may be more important than traditional surgical quality surrogates.",
keywords = "Colon cancer, laparoscopy, lymph node count, quality, survival",
author = "Mathis, {Kellie L.} and Green, {Erin M.} and Sargent, {Daniel J.} and Conor Delaney and Simmang, {Clifford L.} and Heidi Nelson",
year = "2013",
month = "1",
doi = "10.1097/SLA.0b013e318260a8e6",
language = "English (US)",
volume = "257",
pages = "102--107",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing

T2 - A report from the prospective COST trial

AU - Mathis, Kellie L.

AU - Green, Erin M.

AU - Sargent, Daniel J.

AU - Delaney, Conor

AU - Simmang, Clifford L.

AU - Nelson, Heidi

PY - 2013/1

Y1 - 2013/1

N2 - OBJECTIVE: We tested the hypothesis that the 12 lymph node (LN) count and other surgical variables would not predict survival in a setting where surgical techniques were standardized and surgeons were credentialed and audited. BACKGROUND: The National Quality Forum has adopted the 12-node minimum as a surgical quality metric due to the strong association between node count and survival. METHODS: We performed a secondary analysis of data from the Clinical Outcomes of Surgical Therapy (COST) multicenter randomized trial testing laparoscopic versus open colectomy. Surgeons were credentialed and video-audited for adherence to technical standards. Patients with noninvasive and stage IV disease were excluded, leaving 787 subjects (267 stage I, 284 stage II, and 236 stage III). Median age was 70 years and 50% were male. The overall 5-year survival was 77.2%. RESULTS: Five-year overall and disease-free survival was not influenced by LN count (< 12 vs 12), sex, tumor location (right vs left vs sigmoid), surgical technique (laparoscopic vs open), total bowel length, proximal margin, distal margin, radial margin, or mesenteric length (P > 0.05 for all). Univariate predictors of survival included age and cancer stage, and these remained significant in the multivariate model. Across all stages of disease, after adjusting for age and stage, LN count did not predict overall or disease-free survival (P = 0.60). CONCLUSIONS: Despite the known association between LN count and survival, we could not confirm an association between surgical surrogates and cancer outcomes. We postulate that standardization, credentialing, and monitoring may be more important than traditional surgical quality surrogates.

AB - OBJECTIVE: We tested the hypothesis that the 12 lymph node (LN) count and other surgical variables would not predict survival in a setting where surgical techniques were standardized and surgeons were credentialed and audited. BACKGROUND: The National Quality Forum has adopted the 12-node minimum as a surgical quality metric due to the strong association between node count and survival. METHODS: We performed a secondary analysis of data from the Clinical Outcomes of Surgical Therapy (COST) multicenter randomized trial testing laparoscopic versus open colectomy. Surgeons were credentialed and video-audited for adherence to technical standards. Patients with noninvasive and stage IV disease were excluded, leaving 787 subjects (267 stage I, 284 stage II, and 236 stage III). Median age was 70 years and 50% were male. The overall 5-year survival was 77.2%. RESULTS: Five-year overall and disease-free survival was not influenced by LN count (< 12 vs 12), sex, tumor location (right vs left vs sigmoid), surgical technique (laparoscopic vs open), total bowel length, proximal margin, distal margin, radial margin, or mesenteric length (P > 0.05 for all). Univariate predictors of survival included age and cancer stage, and these remained significant in the multivariate model. Across all stages of disease, after adjusting for age and stage, LN count did not predict overall or disease-free survival (P = 0.60). CONCLUSIONS: Despite the known association between LN count and survival, we could not confirm an association between surgical surrogates and cancer outcomes. We postulate that standardization, credentialing, and monitoring may be more important than traditional surgical quality surrogates.

KW - Colon cancer

KW - laparoscopy

KW - lymph node count

KW - quality

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84871616874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871616874&partnerID=8YFLogxK

U2 - 10.1097/SLA.0b013e318260a8e6

DO - 10.1097/SLA.0b013e318260a8e6

M3 - Article

VL - 257

SP - 102

EP - 107

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -